Routine use of continuous positive airway pressure (CPAP) to support preterm infants with
respiratory distress is an evidenced based strategy to decrease the incidence of …

Within the last decades, therapeutic advances have significantly improved the survival of
extremely preterm infants. In contrast, the incidence of major neonatal morbidities, including …

Introduction: There are limited data available regarding the fraction of inspired oxygen
(FiO2) predictive of the failure of continuous positive airway pressure (CPAP) in preterm …

Objective: To compare the effectiveness of surfactant delivery via endotracheal tube (ETT)
using an intubation-surfactant-rapid extubation approach with premedication) vs laryngeal …

Background Early continuous positive airway pressure (CPAP) and surfactant replacement
are effective treatments for neonatal respiratory distress syndrome (RDS). CPAP is the first …

Supporting the respiratory status of the newly born, criti-cally ill premature neonate is a long
held focus of the practicing neonatologist. One could argue that neonatology evolved out of …

To determine the early factors associated with continuous positive airway pressure (CPAP)
failure in moderate-to-late preterm infants (32+ 0/7 to 36+ 6/7 weeks' gestation) from the …

Objective: To determine whether early radiologic evidence of severe respiratory distress
syndrome (RDS) is predictive of nasal continuous positive airway pressure (CPAP) failure in …

The term “hyaline membrane disease” refers to the histological aspect of the most frequent
pulmonary pathology in preterm newborn patients. The lung of the preterm baby is …

Reducing the risk of primary noninvasive ventilation failure in extremely low birthweight
infants is linked to reducing bronchopulmonary dysplasia. In a secondary analysis of …